Pearl Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer and marketer · Islamabad · Pakistan
Islamabad pharmaceutical manufacturer and marketer with a diversified portfolio and local manufacturing facility.
Pearl Pharmaceuticals products in Pakistan
Pearl Pharmaceuticals has 118 medicine presentations registered in Pakistan under 52 brands, covering 46 generic medicines. Most of its products are in Anti-infectives, Dermatology and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Clozole (Clotrimazole), Ptrox (Ceftriaxone), Ximcef (Cefixime) and Hydrovate (Hydrocortisone). 118 products have an official DRAP price on MedInfoBase. See all 52 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer and marketer
- Address
- Plot No. 204, Street No. 1, I-10/3 Industrial Area, Islamabad, Pakistan
- Website
- pearl.com.pk ↗
- Phone
- +92 51 4434775-76; +92 51 4448534; +92 51 4441140
- info@pearl.com.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Pearl Pharmaceuticals is priced against the market
107 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Ceftaprime | Ceftazidime | 250 mg | Injection | 1's | 084386 | PKR 159.94 | PKR 159.94/vial/unit | 🔒 Pharma Pro |
| Ceftaprime | Ceftazidime | 500 mg | Injection | 1's | 084387 | PKR 273.69 | PKR 273.69/vial/unit | 🔒 Pharma Pro |
| Pazidime | Ceftazidime | 1 g | IM/IV injection | 1's | 091639 | PKR 456.98 | PKR 456.98/vial/unit | 🔒 Pharma Pro |
| Pcef | Cefotaxime | 250 mg | Injection | 1's | 055872 | PKR 105.65 | PKR 105.65/vial/unit | 🔒 Pharma Pro |
| Pcef | Cefotaxime | 500 mg | Injection | 1's | 055873 | PKR 159.23 | PKR 159.23/vial/unit | 🔒 Pharma Pro |
| Pcef | Cefotaxime | 1 g | Injection | 1's | 055874 | PKR 286.41 | PKR 286.41/vial/unit | 🔒 Pharma Pro |
| Ptrox | Ceftriaxone | 250 mg | Injection | 1's | 032550 | PKR 169.53 | PKR 169.53/vial/unit | 🔒 Pharma Pro |
| Ptrox | Ceftriaxone | 500 mg | IM injection | 1's | 032551 | PKR 279.23 | PKR 279.23/vial/unit | 🔒 Pharma Pro |
| Ptrox | Ceftriaxone | 1 g | Injection | 1's | 032552 | PKR 558.46 | PKR 558.46/vial/unit | 🔒 Pharma Pro |
| Ptrox | Ceftriaxone | 500 mg | Injection | 1's | 119171 | PKR 351.11 | PKR 351.11/vial/unit | 🔒 Pharma Pro |
| Ptrox | Ceftriaxone | 2 g | Injection | 1's | 119172 | PKR 885.65 | PKR 885.65/vial/unit | 🔒 Pharma Pro |
| Ximcef | Cefixime | 200 mg/5 mL | Dry suspension | 30ml | 056085 | PKR 404.28 | PKR 13.48/mL | 🔒 Pharma Pro |
| Ximcef | Cefixime | 100 mg/5 mL | Dry suspension | 30ml | 056086 | PKR 330.36 | PKR 11.01/mL | 🔒 Pharma Pro |
| Ximcef | Cefixime | 200 mg | Capsule | 5's | 062967 | PKR 313.61 | PKR 62.72/capsule | 🔒 Pharma Pro |
| Ximcef | Cefixime | 200 mg | Capsule | 10's | 062967 | PKR 614.66 | PKR 61.47/capsule | 🔒 Pharma Pro |
| Ximcef | Cefixime | 400 mg | Capsule | 5's | 062968 | PKR 591.99 | PKR 118.40/capsule | 🔒 Pharma Pro |
All 52 Pearl Pharmaceuticals brands in Pakistan
- Amlobest Amlodipine · 10 mg tablet, 5 mg tablet
- Aqua Water for Injection · 10 mL injection, 5 mL injection
- Arbev Doxycycline · 100 mg tablet
- Artepearl Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet
- C-Prime Ascorbic acid · 500 mg tablet
- Ceftaprime Ceftazidime · 250 mg injection, 500 mg injection
- Chloroquine Chloroquine · 250 mg tablet, 50 mg/5 mL syrup
- Claribest Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Clopidro Clopidogrel · 75 mg tablet
- Clozole Clotrimazole · 0.1 g cream, 0.3 g lotion, 500 mg cream
- Clozole Vaginal Clotrimazole · 100 mg tablet
- Clozole-H Clotrimazole + Hydrocortisone · 1% + 1% w/w cream
- Colbex Paracetamol · 120 mg/5 mL suspension, 500 mg tablet
- Corodox Doxycycline · 100 mg capsule
- Cyprex Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- D-Pearl Cholecalciferol · 5 mg/mL injection
- Diprocort Betamethasone dipropionate · 0.0096 g ointment, 0.64 mg cream
- Fair Fluoxetine · 20 mg capsule
- Flezole Metronidazole · 200 mg tablet, 200 mg/5 mL suspension, 400 mg tablet
- Fluka Fluconazole · 150 mg capsule, 50 mg/5 mL suspension
- Fozab Ranitidine · 150 mg tablet
- HQS Hydroxychloroquine · 200 mg tablet
- Hydrovate Hydrocortisone · 1 % cream, 1% cream
- Isopearl Isotretinoin · 0.05 % gel, 10 mg capsule, 20 mg capsule
- Isopearl Softgel Isotretinoin · 20 mg capsule
- Isopearl-E Isotretinoin + Erythromycin · 0.05 % + 2 % gel
- Itrop Itraconazole · 100 mg capsule
- Iverterm Ivermectin · 6 mg tablet
- Kosart Losartan, Losartan + Hydrochlorothiazide · 50 mg tablet, 50 mg + 120 mg tablet
- Lactone 120 ml Lactulose · 3.5 g syrup
- Leksus Loratadine · 10 mg tablet, 5 mg/5 mL syrup
- Linzopearl Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
- Lopinavir-R 200 Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Meriflox Moxifloxacin · 400 mg tablet
- Monolexin Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Monolexin Dry Cephalexin · 100 mg drops
- Netcavir Entecavir · 0.5 mg tablet, 1 mg tablet
- Oprime Omeprazole · 20 mg capsule, 40 mg capsule, 40 mg injection
- Pazidime Ceftazidime · 1 g injection
- Pcef Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Pcodine Paracetamol + Codeine · 500 mg + 15 mg tablet
- Ptrox Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Rexatrex Methotrexate · 2.5 mg tablet
- Scabi-Pearl Permethrin · 5 % lotion, 5% lotion, 5% cream
- Terbipearl Terbinafine · 1 % cream
- Terbipearl Lotion Terbinafine · 1 % lotion
- Tevoflox Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Virolite Aciclovir · 5% w/w ointment
- Ximcef Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 200 mg/5 mL suspension
- Zatrocin Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
- Zepack Azithromycin · 250 mg tablet
- ZoloPearl Cefazolin · 1 g injection, 500 mg injection
Pearl Pharmaceuticals: common questions
How many products does Pearl Pharmaceuticals have in Pakistan?
Pearl Pharmaceuticals has 118 registered medicine presentations in Pakistan, sold under 52 brands and covering 46 generic medicines.
What are the main brands of Pearl Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Clozole (Clotrimazole), Ptrox (Ceftriaxone), Ximcef (Cefixime), Hydrovate (Hydrocortisone) and Leksus (Loratadine). This is not a sales ranking.
Which therapy areas does Pearl Pharmaceuticals cover?
The most products are in Anti-infectives (80), Dermatology (10), Gastrointestinal & hepatology (6), Cardiovascular (5) and Pain & musculoskeletal (4).
Where can I see Pearl Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.